Sec. 21a-114. (Formerly Sec. 19-233). When advertisement of drugs and devices deemed to be false.
Sec. 21a-114. (Formerly Sec. 19-233). When advertisement of drugs and devices deemed to be false. The advertisement of a drug or device representing it to have
any effect in albuminuria, appendicitis, arteriosclerosis, blood poison, bone disease,
Bright's disease, cancer, carbuncles, cholecystitis, diabetes, diphtheria, dropsy, erysipelas, gallstones, heart and vascular diseases, high blood pressure, mastoiditis, measles,
meningitis, mumps, nephritis, otitis media, paralysis, pneumonia, poliomyelitis (infantile paralysis), prostate gland disorders, pyelitis, scarlet fever, sexual impotence, sinus
infection, smallpox, tuberculosis, tumors, typhoid, uremia or venereal disease, shall also
be deemed to be false; except that no advertisement not in violation of section 21a-113
shall be deemed to be false under this section if it is disseminated only to members of
the medical, dental or veterinary profession, or appears only in the scientific periodicals
of these professions, or is disseminated only for the purpose of public health education
by persons not commercially interested, directly or indirectly, in the sale of such drugs
or devices; provided, whenever the commissioner and director, acting jointly, agree that
an advance in medical science has made any type of self-medication safe as to any
of the diseases named above, the commissioner and director, acting jointly, shall, by
regulation, authorize the advertisement of drugs having curative or therapeutic effect
for such disease, subject to such conditions and restrictions as the commissioner and
director, acting jointly, deem necessary in the interests of public health; and provided
this section shall not be construed as indicating that self-medication for diseases other
than those named herein is safe or efficacious.
(1949 Rev., S. 3950.)
History: Sec. 19-233 transferred to Sec. 21a-114 in 1983.